Monday 9 November 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS

Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.

Revenue: −0.28%
EPS: −157.5%
Free cash flow: +38.8%
Total debt: −18.1%

Quarter to September 2026, against a year earlier

20.45 0.54 +2.71%

Follow VTRS

Alert me

Market cap: $22.8B
P/E: n/m
Fwd P/E: n/m
Dividend yield: 2.35%
F-score: 4/9
ROIC: −0.01%
Net debt / EBITDA: 4.9×
Dividend safety: 37/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Viatris Inc. (VTRS) P/E ratio

Alert me on P/E ratio

Viatris Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 762× (February 2020) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VTRS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Viatris Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VTRS/metrics/pe-ratio">Viatris Inc. (VTRS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	228×	3,322.99%
FY2022	6.7×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	670×	1,562.77%
FY2018	40.3×	22.44%
FY2017	32.9×	(23.43%)
FY2016	43.0×	39.10%

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 762×

Ten-year median 23.6×

Current reading's percentile 33

Company	P/E ratio
ELAN Elanco Animal Health Incorporated compare	n/m
VTRS Viatris Inc.	n/m
ZTS Zoetis Inc. compare	14.0×
HLN Haleon PLC Sponsored ADR compare	20.1×
UTHR United Therapeutics Corporation compare	20.4×
NBIX Neurocrine Biosciences, Inc. compare	24.2×
TAK Takeda Pharmaceutical Co. compare	31.7×
RDY Dr. Reddy's Laboratories Ltd compare	46.0×
TEVA Teva Pharmaceutical Industries Ltd. compare	95.2×
Drug Manufacturers Specialty & Generic industry median	20.4×
Healthcare sector median	25.3×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Viatris Inc. (VTRS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on VTRS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on VTRS

Stockrow Weekly